Topics
Medulloblastoma | Treatment | Side effects | Cerebellar mutism syndrome
Home > Publications > Topics > Medulloblastoma > Treatment > Side effects > Cerebellar mutism syndrome
Kameda-Smith MM, Ragulojan M,
Elliott C, Bliss L, Moore H, Sader N, Alsuwaihel M, Tso MK, Dakson
A, Ajani O, Yarascavitch B, Fleming A, Mehta V, Aminnejad M,
Farrokhyar F, Singh SK; McMaster Pediatric Brain Tumour Study
Group (PBTSG) and the Canadian Neurosurgery Research Collaborative
(CNRC).
National
multicentered retrospective review of clinical and intraoperative
factors associated with the development of cerebellar mutism after
pediatric posterior fossa tumor resection.
Childs
Nerv Syst. 2024
Jan 27. doi:
10.1007/s00381-024-06292-0. PMID:
38279985. Observational study˰ ˍ
Turkistani AN, Alsharif TH, Aldhafeeri WF, Aljohani S, Alomar S.
Medical management for cerebellar
mutism syndrome following posterior fossa surgery: A systematic
review.
Clin
Neurol Neurosurg. 2024 May 23;242:108352. doi:
10.1016/j.clineuro.2024.108352. PMID:
38823197. Review.
˰
Laustsen AF, Avula S, Grønbæk
J, Pizer B, Nyman P, Nilsson P, Frič R, Hjort MA, Beneš
V, Hauser P, Pálmafy B, Rutkauskiene G, Wilhelmy F,
Brandsma R, Sehested A, Mathiasen R, Juhler M.
Tumour
volume as a predictor of postoperative speech impairment in
children undergoing resection of posterior fossa tumours: a
prospective, multicentre study.
Acta
Neurochir (Wien).
2025 Apr 3;167(1):97. doi:
10.1007/s00701-025-06459-x. PMID:
40178678. Interventional
study. ˍ